Recommendations to improve the Positive and Negative Syndrome Scale (PANSS) based on item response theory

Psychiatry Research

Volumn 188, Issue 3, 2011, Pages 446-452

  Levine, Stephen Z ^a   Rabinowitz, Jonathan ^a   Rizopoulos, Dimitris ^b  

^a BAR ILAN UNIVERSITY   (Israel)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Item Response Theory; PANSS; Psychometrics; Schizophrenia; Severity of Illness Index

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; ITEM RESPONSE THEORY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGICAL THEORY; PSYCHOMETRY; RELIABILITY; SCHIZOPHRENIA; TOTAL QUALITY MANAGEMENT; VALIDATION PROCESS;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WEIGHTS AND MEASURES; YOUNG ADULT;

EID: 79960696959     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.03.014     Document Type: Article

References (49)

1. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 2005, 162:441-449.
2. Bagby R.M., Ryder A.G., Schuller D.R., Marshall M.B. The Hamilton Depression Rating Scale: has the gold standard become a lead weight?. American Journal of Psychiatry 2004, 161:2163-2177.
3. Baker F. The Basics of Item Response Theory 2001, ERIC Clearinghouse on Assessment and Evaluation, University of Maryland College Park, MD.
4. Bell M.D., Lysaker P.H., Beam-Goulet J.L., Milstein R.M., Lindenmayer J.P. Five-component model of schizophrenia: assessing the factorial invariance of the Positive and Negative Syndrome Scale. Psychiatry Research 1994, 52:295-303.
5. Bernstein I.H., Rush A.J., Carmody T.J., Woo A., Trivedi M.H. Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample. Joural of Psychiatric Research 2007, 41:239-246.
6. Corrigan M.H., Gallen C.C., Bonura M.L., Merchant K.M. Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial. Biological Psychiatry 2004, 55:445-451.
7. Embretson S.E., Reise S.P. Item Response Theory for Psychologists 2000, Lawrence Erlbaum Associates, Mahwah, NJ.
8. Emsley R.A., Niehaus D.J., Mbanga N.I., Oosthuizen P.P., Stein D.J., Maritz J.S., Pimstone S.N., Hayden M.R., Laurent C., Deleuze J.F., Mallet J. The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia. Schizophrenia Research 2001, 47:149-157.
9. Emsley R.A., Rabinowitz J., Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophrenia Research 2003, 61:47-57.
10. Gorsuch R.L. Factor Analysis 1993, Lawrence Erlbaum Associates, New Jersey. 2nd ed.
11. Higashima M., Urata K., Kawasaki Y., Maeda Y., Sakai N., Mizukoshi C., Nagasawa T., Kamiya T., Yamaguchi N., Koshino Y. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia. Biological Psychiatry 1998, 44:115-120.
12. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
13. Kinon B.J., Chen L., Ascher-Svanum H., Stauffer V.L., Kollack-Walker S., Zhou W., Kapur S., Kane J.M. Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychopharmacology 2009, 35:581-590.
14. Kline P. The Handbook of Psychological Testing 1993, Routledge, London. 2nd ed.
15. Lancon C., Aghababian V., Llorca P.M., Auquier P. Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis. Acta Psychiatrica Scandinavica 1998, 98:369-376.
16. Lancon C., Auquier P., Nayt G., Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophrenia Research 2000, 42:231-239.
17. Lehoux C., Gobeil M., Lefèbvre A., Maziade M., Roy M. The five-factor structure of the PANSS: a critical review of its consistency across studies. Clinical Schizophrenia & Related Psychoses 2009, 3:231-239.
18. Leucht S., Davis J.M., Engel R.R., Kane J.M., Wagenpfeil S. Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 2007, 32:1903-1910.
19. Leucht S., Davis J.M., Engel R.R., Kissling W., Kane J.M. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation. Acta Psychiatrica Scandinavica Supplement 2009, 7-14.
20. Leucht S., Kissling W., Davis J.M. The PANSS should be rescaled. Schizophrenia Bulletin 2010, 36:461-462.
21. Levine S.Z., Rabinowitz J. Revisiting the 5 dimensions of the positive and negative syndrome scale. Journal of Clinical Psychopharmacology 2007, 27:431-436.
22. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., Hsiao J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005, 353:1209-1223.
23. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S. A new five factor model of schizophrenia. Psychiatry Quarterly 1994, 65:299-322.
24. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S., Bark N. Psychopathology of schizophrenia: initial validation of a 5-factor model. Psychopathology 1995, 28:22-31.
25. Lindenmayer J.P., Grochowski S., Hyman R.B. Five factor model of schizophrenia: replication across samples. Schizophrenia Research 1995, 14:229-234.
26. Lykouras L., Oulis P., Psarros K., Daskalopoulou E., Botsis A., Christodoulou G.N., Stefanis C. Five-factor model of schizophrenic psychopathology: how valid is it?. European Archives of Psychiatry and Clinical Neuroscience 2000, 250:93-100.
27. Marder S.R., Davis J.M., Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. Journal of Clinical Psychiatry 1997, 58:538-546.
28. Mass R., Schoemig T., Hitschfeld K., Wall E., Haasen C. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale. Schizophrenia Bulletin 2000, 26:167-177.
29. Minor K.L., Wright B.D., Park S. The smell identification test as a measure of olfactory identification ability in schizophrenia and healthy populations: a Rasch psychometric study. Journal of Abnormal Psychology 2004, 113:207-216.
30. Muller M.J., Wetzel H. Improvement of inter-rater reliability of PANSS items and subscales by a standardized rater training. Acta Psychiatrica Scandinavica 1998, 98:135-139.
31. Nunnally J.C., Bernstein I.H. Psychometric Theory 1978, McGraw-Hill, London.
32. Obermeier M., Mayr A., Schennach-Wolff R., Seemuller F., Moller H.J., Riedel M. Should the PANSS be rescaled?. Schizophrenia Bulletin 2010, 36:455-460.
33. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychological Reports 1962, 10:790-812.
34. Rabinowitz J., Davidson M. Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: a post hoc analysis. Schizophrenia Research 2001, 50:89-93.
35. Reise S.P., Henson J.M. A discussion of modern versus traditional psychometrics as applied to personality assessment scales. Journal of Personality Assessment 2003, 81:93-103.
36. Reise S.P., Yu J.Y. Parameter recovery in the graded response model using multilog. Journal of Educational Measurement 1990, 27:133-144.
37. Rizopoulos D. ltm: an r package for latent variable modelling and item response theory analyses. Journal of Statistical Software 2006, 17:1-25.
38. Rush A.J., Bernstein I.H., Trivedi M.H., Carmody T.J., Wisniewski S., Mundt J.C., Shores-Wilson K., Biggs M.M., Woo A., Nierenberg A.A., Fava M. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biological Psychiatry 2006, 59:493-501.
39. Samejima F. Estimation of latent ability using a response pattern of graded scores. Psychometrika Monograph 1969, 17.
40. Santor D.A., Ascher-Svanum H., Lindenmayer J.P., Obenchain R.L. Item response analysis of the Positive and Negative Syndrome Scale. BMC Psychiatry 2007, 7:66.
41. Schooler N., Rabinowitz J., Davidson M., Emsley R., Harvey P.D., Kopala L., McGorry P.D., Van Hove I., Eerdekens M., Swyzen W., De Smedt G. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. American Journal of Psychiatry 2005, 162:947-953.
42. Schultz-Larsen K., Lomholt R.K., Kreiner S. A short form of MMSE was as accurate as the original in predicting dementia. Journal of Clinical Epidemiology 2007, 60:260-267.
43. Singh M.M., Kay S.R. A comprehensive study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia: theoretical implications for potency differences among neuroleptics. Psychopharmacologia 1975, 43:115-123.
44. Strous R.D., Maayan R., Lapidus R., Stryjer R., Lustig M., Kotler M., Weizman A. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Archives of General Psychiatry 2003, 60:133-141.
45. Thompson P.A., Buckley P.F., Meltzer H.Y. The brief psychiatric rating scale: effect of scaling system on clinical response assessment. Journal of Clinical Psychopharmacology 1994, 14:344-346.
46. Thompson K., Kulkarni J., Sergejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research 2000, 42:241-247.
47. van der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophrenia Research 2006, 82:213-223.
48. Wolthaus J.E., Dingemans P.M., Schene A.H., Linszen D.H., Knegtering H., Holthausen E.A., Cahn W., Hijman R. Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology (Berl) 2000, 150:399-403.
49. Young M.A., Blodgett C., Reardon A. Measuring seasonality: psychometric properties of the Seasonal Pattern Assessment Questionnaire and the Inventory for Seasonal Variation. Psychiatry Research 2003, 117:75-83.